WallStSmart

Brookfield Business Corp (BBUC)vsHarte Hanks Inc (HHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Brookfield Business Corp generates 17327% more annual revenue ($26.95B vs $154.63M). BBUC leads profitability with a -0.2% profit margin vs -3.7%. BBUC earns a higher WallStSmart Score of 55/100 (C-).

BBUC

Buy

55

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 5.0Quality: 4.5
Piotroski: 5/9Altman Z: 0.77

HHS

Avoid

33

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 4.3Quality: 5.5
Piotroski: 3/9Altman Z: 14.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BBUC.

HHSSignificantly Overvalued (-54.3%)

Margin of Safety

-54.3%

Fair Value

$1.86

Current Price

$4.20

$2.34 premium

UndervaluedFair: $1.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BBUC2 strengths · Avg: 9.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
45.8%8/10

Earnings expanding 45.8% YoY

HHS2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
14.4910/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

BBUC4 concerns · Avg: 2.0/10
Return on EquityProfitability
-11.1%2/10

ROE of -11.1% — below average capital efficiency

Revenue GrowthGrowth
-3.0%2/10

Revenue declined 3.0%

Free Cash FlowQuality
$-718.59M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.772/10

Distress zone — elevated risk

HHS4 concerns · Avg: 2.8/10
Market CapQuality
$31.61M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.573/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-5.2%2/10

ROE of -5.2% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BBUC

The strongest argument for BBUC centers on Price/Book, EPS Growth.

Bull Case : HHS

The strongest argument for HHS centers on Altman Z-Score, Price/Book. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bear Case : BBUC

The primary concerns for BBUC are Return on Equity, Revenue Growth, Free Cash Flow. Debt-to-equity of 8.41 is elevated, increasing financial risk.

Bear Case : HHS

The primary concerns for HHS are Market Cap, Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.57 is elevated, increasing financial risk.

Key Dynamics to Monitor

BBUC carries more volatility with a beta of 1.34 — expect wider price swings.

HHS is growing revenue faster at -1.7% — sustainability is the question.

HHS generates stronger free cash flow (-2M), providing more financial flexibility.

Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BBUC scores higher overall (55/100 vs 33/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Brookfield Business Corp

INDUSTRIALS · CONGLOMERATES · USA

Brookfield Business Corporation focuses on healthcare, construction and wastewater services in the United States, Europe, Australia, the United Kingdom, Canada and Brazil. The company is headquartered in New York, New York.

Harte Hanks Inc

INDUSTRIALS · CONGLOMERATES · USA

Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?